Scientists have discovered that aspirin may prevent cancer metastasis by reducing TXA2 levels, which suppress T cells. Scientists have identified the mechanism by which aspirin may help reduce the spread of certain cancers by activating the immune system,

Scientists have uncovered how the cheap painkiller aspirin can help stop cancers from spreading. Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers, such as breast, bowel, and prostate cancers.

Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but risks remain.

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.

Scientists have discovered how aspirin helps the immune system prevent cancer from spreading. The study reveals that aspirin reduces metastasis by blocking a protein that suppresses immune cells. While promising,

Learn how a staple from our medicine cabinet has the potential to support the immune system in combating metastatic cancer.

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the immune system.

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the immune system.

Scientists have discovered that aspirin reduces cancer metastasis by inhibiting thromboxane A2 (TXA2), which suppresses T cells, potentially leading to targeted cancer treatments. Scientists have uncovered the mechanism by which aspirin stimulates the immune system and can reduce the metastasis of some cancers.